Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,815 | Dovepress* | 5,674+ | 359 | 6,033 | |
PubMed Central* | 141 | 83 | 224 | ||
Totals | 5,815 | 442 | 6,257 | ||
*Since 16 May 2022 |
View citations on PubMed Central and Google Scholar